A detailed history of Jane Street Group, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Jane Street Group, LLC holds 144,264 shares of ABT stock, worth $16.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
144,264
Previous 897,433 83.92%
Holding current value
$16.5 Million
Previous $93.3 Million 82.36%
% of portfolio
0.0%
Previous 0.11%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$100.07 - $118.13 $75.4 Million - $89 Million
-753,169 Reduced 83.92%
144,264 $16.4 Million
Q2 2024

Aug 14, 2024

BUY
$100.73 - $112.44 $52.5 Million - $58.6 Million
521,544 Added 138.75%
897,433 $93.3 Million
Q1 2024

May 15, 2024

SELL
$109.52 - $120.96 $31.3 Million - $34.6 Million
-285,687 Reduced 43.18%
375,889 $42.7 Million
Q4 2023

Feb 14, 2024

BUY
$90.19 - $110.4 $30.1 Million - $36.9 Million
334,257 Added 102.12%
661,576 $72.8 Million
Q3 2023

Nov 14, 2023

SELL
$95.53 - $114.62 $12.1 Million - $14.5 Million
-126,802 Reduced 27.92%
327,319 $31.7 Million
Q2 2023

Aug 14, 2023

BUY
$100.78 - $112.29 $25 Million - $27.8 Million
247,810 Added 120.11%
454,121 $49.5 Million
Q1 2023

May 15, 2023

BUY
$96.86 - $114.01 $17.6 Million - $20.7 Million
181,369 Added 727.16%
206,311 $20.9 Million
Q4 2022

Feb 14, 2023

SELL
$95.06 - $111.52 $15.4 Million - $18.1 Million
-162,079 Reduced 86.66%
24,942 $2.74 Million
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $49.8 Million - $57.6 Million
-514,326 Reduced 73.33%
187,021 $18.1 Million
Q2 2022

Aug 16, 2022

BUY
$102.07 - $123.37 $52.6 Million - $63.6 Million
515,636 Added 277.66%
701,347 $76.2 Million
Q1 2022

May 17, 2022

BUY
$114.02 - $139.04 $177,757 - $216,763
1,559 Added 0.85%
185,711 $22 Million
Q4 2021

Feb 15, 2022

BUY
$115.53 - $141.46 $9.84 Million - $12.1 Million
85,187 Added 86.08%
184,152 $25.9 Million
Q3 2021

Nov 16, 2021

SELL
$116.66 - $129.06 $44.4 Million - $49.1 Million
-380,208 Reduced 79.35%
98,965 $11.7 Million
Q2 2021

Aug 16, 2021

BUY
$105.79 - $124.53 $10.4 Million - $12.3 Million
98,675 Added 25.93%
479,173 $55.6 Million
Q1 2021

May 18, 2021

BUY
$108.84 - $128.23 $34.7 Million - $40.9 Million
318,602 Added 514.74%
380,498 $45.6 Million
Q4 2020

Feb 17, 2021

BUY
$105.0 - $114.42 $2.62 Million - $2.86 Million
24,952 Added 67.54%
61,896 $6.78 Million
Q3 2020

Nov 17, 2020

SELL
$91.64 - $111.29 $1.96 Million - $2.38 Million
-21,412 Reduced 36.69%
36,944 $4.02 Million
Q2 2020

Aug 17, 2020

SELL
$76.57 - $98.0 $3.49 Million - $4.47 Million
-45,576 Reduced 43.85%
58,356 $5.34 Million
Q1 2020

May 15, 2020

BUY
$62.82 - $91.86 $5.1 Million - $7.46 Million
81,232 Added 357.85%
103,932 $8.2 Million
Q4 2019

Feb 14, 2020

SELL
$78.51 - $87.4 $2.21 Million - $2.46 Million
-28,167 Reduced 55.37%
22,700 $1.97 Million
Q3 2019

Nov 14, 2019

SELL
$81.84 - $88.74 $3.15 Million - $3.41 Million
-38,432 Reduced 43.04%
50,867 $4.26 Million
Q2 2019

Aug 15, 2019

BUY
$72.88 - $85.0 $1.68 Million - $1.96 Million
23,070 Added 34.83%
89,299 $7.51 Million
Q1 2019

May 16, 2019

BUY
$66.22 - $80.06 $4.03 Million - $4.87 Million
60,802 Added 1120.36%
66,229 $5.29 Million
Q4 2018

Feb 15, 2019

SELL
$65.56 - $74.27 $796,029 - $901,786
-12,142 Reduced 69.11%
5,427 $393,000
Q3 2018

Nov 14, 2018

SELL
$60.81 - $73.36 $6.11 Million - $7.37 Million
-100,447 Reduced 85.11%
17,569 $1.29 Million
Q2 2018

Aug 15, 2018

SELL
$57.57 - $63.54 $296,658 - $327,421
-5,153 Reduced 4.18%
118,016 $7.2 Million
Q1 2018

May 15, 2018

BUY
$56.27 - $63.62 $2.21 Million - $2.5 Million
39,230 Added 46.74%
123,169 $7.38 Million
Q4 2017

Feb 15, 2018

BUY
$53.68 - $57.47 $2.36 Million - $2.53 Million
44,016 Added 110.25%
83,939 $4.79 Million
Q3 2017

Nov 14, 2017

BUY
$48.06 - $53.64 $1.92 Million - $2.14 Million
39,923
39,923 $2.13 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.